Name · Molecular Health GmbH – a dievini Hopp BioTech Company Address/P.O. Box Postal Code/City State Contact Person Telephone Fax Email Address Internet Website Social Media Number of Employees Founded (year)
· · · · · · · · · · ·
Kurfuersten-Anlage 21 69115 Heidelberg Baden-Wuerttemberg Thomas König (Head of Marketing & PR) +49-6221-43851-0 +49-6221-43-2270 thomas.koenig@molecularhealth.com www.molecularhealth.com
FL I Q 126 (Germany/USA) 2004
Areas of Activity · Computational Biomedicine/ Biotechnology External · l FDA Collaborations l SAP l Techniker Krankenkasse l Charité l dkfz l Universität Heidelberg l Hanse Merkur l Karolinska Institut l Berlin Institute of Health l Daten Capital LLP l etc …
Molecular Health: making precision medicine a reality Molecular Health is an international biotech company headquartered in Germany that has been developing innovative software in the field of in-silico and precision medicine since 2004. Our solutions enable the conversion of large volumes of data into evidence-based, medically relevant results for healthcare professionals. We provide molecular pathologists, human geneticists, physicians, and patients with comprehensive information about diagnoses and treatment options. We support pharmaceutical and health organisations in optimising clinical studies and developing disease models. At Molecular Health, specialists from the fields of medicine, data science, biology, and bioinformatics, as well as software development, strive to make Big Data work for healthcare. The result is a range of intuitive high-performance applications tailored to a broad spectrum of requirements in healthcare.
Molecular Health Guide (MH Guide): transforming molecular data into evidence-based decisions MH Guide supports molecular pathologists and other qualified medical professionals in the clinical annotation of genetic variants, enabling physicians to make precision oncology decisions. MH Guide is approved as an in-vitro diagnostic medical device in Europe. The customisable software application provides access to data derived from the world-class knowledge database Dataome, so that treatment decisions are based on upto-date clinical and molecular information. MH Guide also has two components specifically designed for the analysis of hereditary diseases. Molecular Health Guide BRCA (MH BRCA) is optimised for the diagnosis of hereditary breast and ovarian cancer syndrome (HBOC). It is designed for use by human geneticists and laboratories evaluating BRCA1, BRCA2, and other HBOC-related genes. Molecular Health Guide Mendel (MH Mendel) supports human geneticists in identifying clinically important genetic variants for hereditary diseases and predispositions other than HBOC.